Treatment of Peyronie's Disease With Platelet-Rich Plasma

NAActive, not recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 10, 2025

Primary Completion Date

October 1, 2025

Study Completion Date

January 1, 2026

Conditions
Peyronies Disease
Interventions
OTHER

Autologous Platelet Rich Plasma

10 mL PRP intralesional injections will be administered. After the injections, participants will be instructed to perform penile stretching exercises daily until the next injection and to continue these exercises after the final injection until the 3-month follow-up.

OTHER

Saline solution

10 mL saline solution intralesional injections will be administered. After the injections, participants will be instructed to perform penile stretching exercises daily until the next injection and to continue these exercises after the final injection until the 3-month follow-up.

Trial Locations (1)

2730

Herlev and Gentofte University Hospital, Herlev

All Listed Sponsors
lead

Herlev Hospital

OTHER

NCT06789510 - Treatment of Peyronie's Disease With Platelet-Rich Plasma | Biotech Hunter | Biotech Hunter